Cargando…

Metabolic contrast agents produced from transported solid (13)C-glucose hyperpolarized via dynamic nuclear polarization

Magnetic Resonance Imaging combined with hyperpolarized (13)C-labelled metabolic contrast agents produced via dissolution Dynamic Nuclear Polarization can, non-invasively and in real-time, report on tissue specific aberrant metabolism. However, hyperpolarization equipment is expensive, technically d...

Descripción completa

Detalles Bibliográficos
Autores principales: Capozzi, Andrea, Kilund, Jan, Karlsson, Magnus, Patel, Saket, Pinon, Arthur Cesar, Vibert, François, Ouari, Olivier, Lerche, Mathilde H., Ardenkjær-Larsen, Jan Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814755/
https://www.ncbi.nlm.nih.gov/pubmed/36697707
http://dx.doi.org/10.1038/s42004-021-00536-9
Descripción
Sumario:Magnetic Resonance Imaging combined with hyperpolarized (13)C-labelled metabolic contrast agents produced via dissolution Dynamic Nuclear Polarization can, non-invasively and in real-time, report on tissue specific aberrant metabolism. However, hyperpolarization equipment is expensive, technically demanding and needs to be installed on-site for the end-user. In this work, we provide a robust methodology that allows remote production of the hyperpolarized (13)C-labelled metabolic contrast agents. The methodology, built on photo-induced thermally labile radicals, allows solid sample extraction from the hyperpolarization equipment and several hours’ lifetime of the (13)C-labelled metabolic contrast agents at appropriate storage/transport conditions. Exemplified with [U-(13)C, d(7)]-D-glucose, we remotely produce hyperpolarized (13)C-labelled metabolic contrast agents and generate above 10,000-fold liquid-state Magnetic Resonance signal enhancement at 9.4 T, keeping on-site only a simple dissolution device.